198 related articles for article (PubMed ID: 35493099)
1. Expression, Prognostic Value, and Functional Mechanism of the KDM5 Family in Pancreatic Cancer.
Duan Y; Du Y; Gu Z; Zheng X; Wang C
Front Cell Dev Biol; 2022; 10():887385. PubMed ID: 35493099
[No Abstract] [Full Text] [Related]
2. Systemic Profiling of KDM5 Subfamily Signature in Non-Small-Cell Lung Cancer.
Hao F
Int J Gen Med; 2021; 14():7259-7275. PubMed ID: 34737620
[TBL] [Abstract][Full Text] [Related]
3. KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas.
Wang D; Zhang Y; Liao Z; Ge H; Güngör C; Li Y
Sci Rep; 2023 Oct; 13(1):18250. PubMed ID: 37880235
[TBL] [Abstract][Full Text] [Related]
4. Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.
Zhang J; Tian Y; Mo S; Fu X
Int J Gen Med; 2022; 15():3077-3096. PubMed ID: 35330878
[TBL] [Abstract][Full Text] [Related]
5. Characterization of KDM5 lysine demethylase family substrate preference and identification of novel substrates.
Hoekstra M; Ridgeway NH; Biggar KK
J Biochem; 2022 Dec; 173(1):31-42. PubMed ID: 36205465
[TBL] [Abstract][Full Text] [Related]
6. KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic.
Zhang SM; Cao J; Yan Q
Adv Exp Med Biol; 2023; 1433():113-137. PubMed ID: 37751138
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
Front Oncol; 2020; 10():606735. PubMed ID: 33604289
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
9. Physical and functional interactions between the histone H3K4 demethylase KDM5A and the nucleosome remodeling and deacetylase (NuRD) complex.
Nishibuchi G; Shibata Y; Hayakawa T; Hayakawa N; Ohtani Y; Sinmyozu K; Tagami H; Nakayama J
J Biol Chem; 2014 Oct; 289(42):28956-70. PubMed ID: 25190814
[TBL] [Abstract][Full Text] [Related]
10. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration.
Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y
Front Genet; 2022; 13():1022626. PubMed ID: 36685833
[No Abstract] [Full Text] [Related]
11. Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma.
Duan Y; Du Y; Mu Y; Gu Z; Wang C
Front Mol Biosci; 2022; 9():1096679. PubMed ID: 36589239
[No Abstract] [Full Text] [Related]
12. Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma.
Duan Y; Du Y; Gu Z; Zheng X; Wang C
Front Mol Biosci; 2022; 9():1036287. PubMed ID: 36339709
[No Abstract] [Full Text] [Related]
13. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
14. PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis.
Bao L; Sun K; Zhang X
Channels (Austin); 2021 Dec; 15(1):680-696. PubMed ID: 34796785
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Yin L; Xiao L; Gao Y; Wang G; Gao H; Peng Y; Zhu X; Wei J; Miao Y; Jiang K; Lu Z
Med Oncol; 2020 Apr; 37(5):46. PubMed ID: 32277286
[TBL] [Abstract][Full Text] [Related]
16. KDM5 demethylases and their role in cancer cell chemoresistance.
Plch J; Hrabeta J; Eckschlager T
Int J Cancer; 2019 Jan; 144(2):221-231. PubMed ID: 30246379
[TBL] [Abstract][Full Text] [Related]
17. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Li CY; Wang W; Leung CH; Yang GJ; Chen J
Mol Cancer; 2024 May; 23(1):109. PubMed ID: 38769556
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification.
Jiang C; Wang M; Yao W; Lv G; Liu X; Wang G
Front Mol Biosci; 2022; 9():778857. PubMed ID: 35433829
[No Abstract] [Full Text] [Related]
19. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
Li Y; Liu Z; Zhang Y
BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma.
Huang Z; Lai H; Liao J; Cai J; Li B; Meng L; Wang W; Mo X; Qin H
Front Oncol; 2021; 11():729230. PubMed ID: 34604068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
